Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
Clinical trial NCT02428296 · COMPLETED
Trial details
- NCT number
- NCT02428296
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-23
- Primary completion
- 2018-02-14
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.